EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

NCT06401421 · clinicaltrials.gov ↗

RECRUITING

Status

1800

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST: ctDNA MRD test

Sponsor

Exact Sciences Corporation

Collaborators

[object Object]